Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.5140
-0.0049 (-0.94%)
At close: Nov 13, 2026, 4:00 PM EST
0.5100
-0.0040 (-0.78%)
After-hours: Nov 13, 2026, 6:41 PM EST
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $22.36 million as of November 13, 2026. It is the 35,908th most valuable company in the world and the 5,091st biggest in the United States. Its market cap has decreased by 71.81% in one year.
Market Cap
22.36M
Enterprise Value
22.21M
1-Year Change
-71.81%
Global Rank
Country Rank
#5,091 United States
Category
ChartMarket Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $22.36M, an increase of 1,157.76%. That is a compound annual growth rate of 86.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 22.36M | -62.05% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 25.57M |
| Lite Strategy | 25.30M |
| Evaxion | 25.27M |
| Immutep | 24.97M |
| BeyondSpring | 24.72M |
| ABVC BioPharma | 23.63M |
| CEL-SCI | 22.51M |
| TransCode Therapeutics | 22.35M |